Human meningitis virus

Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis. Methods for rapid diagnosis of meningitis etiology in adults. Biomark Med. Kim JV, et al. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation.

J Infect Dis. Wong KT, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. Munster VJ, et al. Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci Rep. Frei K, et al. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis.

Evaluation in a murine model infection and in patients. J Exp Med. Ramilo O, et al. Am J Dis Child. Enteroviruses: a gut-wrenching game of entry, detection, and evasion. Akuzawa N, et al. Myocarditis, hepatitis, and pancreatitis in a patient with coxsackievirus A4 infection: a case report. Chapter 32—picornaviruses. Mereaux J, et al. Enterovirus infection during pregnancy: Underestimated cause of fetal and neonatal complications?

Molecular pathogenicity of enteroviruses causing neurological disease. Front Microbiol. Rotbart HA Viral meningitis. In: Seminars in neurology. Huang H-I, et al. Enterovirus 71 infects brain-derived neural progenitor cells. Puccini JM, et al. Distinct neural stem cell tropism, early immune activation, and choroid plexus pathology following coxsackievirus infection in the neonatal central nervous system. Lab Invest. Brown DM, et al. Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells.

Palacios G, Oberste M. Enteroviruses as agents of emerging infectious diseases. J Neurovirol. Enterovirus and parechovirus infection in children: a brief overview. Berger JR, et al. Persistent coxsackie B encephalitis: report of a case and review of the literature.

J NeuroVirol. Tabor-Godwin JM, et al. A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS.

J Neurosci. Neurotropic enterovirus infections in the central nervous system. Opavsky MA, et al. J Clin Investig. Hwang JY, et al. Characterization of infections of human leukocytes by non-polio enteroviruses. Jmii H et al Immunopathology in the brain of mice following vertical transmission of Coxsackievirus B4.

Microb Pathog [ PubMed ]. Kim H-J, et al. Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in Structural basis of nonenveloped virus cell entry.

Adv Protein Chem. Lee J-W, et al. Enterovirus Dassociated respiratory and neurological illness in Spain, — Emerg Microbes Infect. Esposito S, et al.

Enterovirus D68 infection. Current understanding of human enterovirus D Wei W, et al. Cell Host Microbe. Messacar K, et al. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Content Repository Only! Johannessen I, Burns SM, et al. In: Greenwood D, et al. Wolthers KC, et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Westerhuis B The 3-dimensional play of human parechovirus infection; cell, virus and antibody.

Karelehto E, et al. Polarized entry of human parechoviruses in the airway epithelium. Front Cell Infect Microbiol. Spear PG, Longnecker R. Herpesvirus entry: an update. J Virol. Primary and recurrent herpes simplex virus type 2-induced meningitis. Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Akkoc G et al Epstein-Barr virus encephalitis in an immunocompetent child: a case report and management of Epstein-Barr virus encephalitis.

Virus infections in the nervous system. Focal encephalitis, meningitis, and acute respiratory distress syndrome associated with influenza A infection. Med Princ Pract. Neurologic complications of influenza A H1N1 Neurology.

Xia J-B, et al. H7N9 influenza A-induced pneumonia associated with acute myelitis in an adult. Intern Med. Yamada M, et al. Multiple routes of invasion of wild-type Clade 1 highly pathogenic avian influenza H5N1 virus into the central nervous system CNS after intranasal exposure in ferrets.

Acta Neuropathol. Siegers JY, et al. Viral factors important for efficient replication of influenza A viruses in cells of the central nervous system. Imai M, Kawaoka Y. The role of receptor binding specificity in interspecies transmission of influenza viruses.

Curr Opin Virol. Kim M, et al. Comparative analyses of influenza virus receptor distribution in the human and mouse brains. J Chem Neuroanat. Miller BR. Lim P-Y, et al. Keratinocytes are cell targets of West Nile virus in vivo. Lim SM, et al. West Nile virus: immunity and pathogenesis. Bookstaver PB, et al. Management of viral central nervous system infections: a primer for clinicians. J Cent Nerv Syst Dis. Pevear DC, et al.

Activity of pleconaril against enteroviruses. Romero JR. Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs. Abzug MJ, et al. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Paintsil E, Cheng Y-C. Antiviral agents. In: Schaechter M, editor. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir.

Scand J Infect Dis. Hassan STS, et al. Molecules Basel, Switzerland ; 24 16 Aurelius E, et al. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Kato K, et al. Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: case report.

J Infect Chemother. Yi E-J, et al. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res. Dai W, et al. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Hudson JA, et al. Outcomes beyond hospital discharge in infants and children with viral meningitis: a systematic review. Rev Med Virol. Biaukula VL, et al. Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae.

Nigrovic LE, et al. Trends in the management of viral meningitis at United States children's hospitals. Frantzidou F, et al.

Aseptic meningitis and encephalitis because of herpesviruses and enteroviruses in an immunocompetent adult population. Doctors diagnose meningitis by ordering specific lab tests on specimens from a person suspected of having meningitis. If a doctor suspects meningitis, he or she may collect samples for testing by. In most cases, there is no specific treatment for viral meningitis. Most people who get mild viral meningitis usually recover completely in 7 to 10 days without treatment.

Antiviral medicine may help people with meningitis caused by viruses such as herpesvirus and influenza. Antibiotics do not help viral infections, so they are not useful in the treatment of viral meningitis. However, antibiotics do fight bacteria, so they are very important when treating bacterial meningitis. People who develop severe illness, or are at risk for developing severe illness, may need care in a hospital. There are no vaccines available in the United States to protect against non-polio enteroviruses, which are the most common cause of viral meningitis.

The best way to help protect yourself and others from non-polio enterovirus infections is to. Vaccines can protect against some diseases, such as measles, mumps, chickenpox, and influenza, which can lead to viral meningitis. Make sure you and your child are vaccinated on schedule. Control mice and rats. If you have a rodent in or around your home, follow appropriate cleaning and control precautions.

Top of Page. Skip directly to site content Skip directly to page options Skip directly to A-Z link. No patient took oral antiviral treatment at the time of presentation. Mollaret cells were never detected. There was no consistent relationship to genital herpes. The duration of treatment with intravenous acyclovir ranged from 3 to 14 days for the first meningitic episode daily dose range from to 1, mg and total dose range from mg q8h for 3 days to mg q8h for 14 days.